Jon Rees
CEO and co-founder at MitoRx Therapeutics
Jon Rees is the CEO and co-founder at MitoRx Therapeutics. He has 16 years of working experience in industry including business development for Takeda Pharma Rare Diseases, VC deal sourcing for LSP.vc, successfully advising Ducentis BioTherapeutics on fundraising. Tranformative decade as spin-out CEO of leading biotech network OBN/BioTrinity. PKD patient charity trustee.
Jon completed his post-doc at the University of Oxford, PhD from the Royal Holloway University of London, a Masters with Distinction from LJMU and a BSc from University of Manchester Institute for Science and Technology.
Visit website: https://www.mitorxtherapeutics.com/#Our-team#JonRees
See also: MitoRx Therapeutics - Pre-clinical stage rare disease biotech company aiming to develop treatments for degenerative diseases
Details last updated 26-Apr-2022
Jon Rees is also referenced in the following:
MitoRx Therapeutics
Pre-clinical stage rare disease biotech company aiming to develop treatments for degenerative diseases
Jon Rees News
MitoRx Therapeutics' CEO shares insights on fundraising and pitching to investors
UK Innovation & Science Seed Fund - 20-Jul-2022
Effectively communicating to investors will translate an ideology into a social benefit
Read more...New longevity startup MitoRx Therapeutics is developing mitochondria protective drugs
Longevity Technology - 25-Apr-2022
Targeting age-related diseases, the company's pre-clinical compounds to progress to the clinic
Read more...